approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 245d ago
- approvalIBANDRONATE SODIUM — FDA approvalJul 25, 2025 · 438d ago
same company · ±60 days · 6
- approvalCOLCHICINE: COLCHICINE — FDA approvalFeb 13, 2026
- approvalFENOFIBRATE: FENOFIBRATE — FDA approvalJan 21, 2026
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
- approvalLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJan 15, 2026
- approvalDILTIAZEM HYDROCHLORIDE: DILTIAZEM HYDROCHLORIDE — FDA approvalFeb 27, 2026
- approvalMOXIFLOXACIN HYDROCHLORIDE: MOXIFLOXACIN HYDROCHLORIDE — FDA approvalMar 2, 2026
comments(0)
5-min edit window · permanent after that